FanZhuo Capital
凡卓资本
FanZhuo Capital is a Chinese financial advisory and investment firm founded and led by Jing Li as its CEO . The firm has served as an exclusive financial advisor on deals, including LifeTech Scientific's 2020 funding round where it also participated as a co-investor alongside Morningside, Matrix Partners China, and others . As described by 暗涌Waves in late 2022, Li noted the firm had increasingly focused on connecting portfolio companies with local government policies and industrial ecosystems to identify suitable landing spots . elsewhere's corpus does not cover FanZhuo Capital's founding date, AUM, or detailed strategy beyond these points.
AI-generated — may contain errors, please verify.
Coverage
Three Barometers for the Primary Market, for Your Reference
The bilateral order of the primary market is being restructured on both sides.
5Y News | Sensors Data Closes $200 Million Series D Round
Boost efficiency through scientific methods.
Morningside-backed LifeTech Scientific raises over RMB 1.2 billion in new funding round | Light Moments
China's new drug R&D is undergoing a "Cambrian explosion." The industry's underlying infrastructure for pharmaceutical innovation is one of the core sectors we're tracking in healthcare.
Niu Technologies IPO Lands on Nasdaq; 3 Companies Close Funding Rounds; Code Brain Issue 8 Mines India | Code Brain Newsletter · October
【Source Code Capital Newsletter】Here we record the small steps forward taken by our team members, share the joy of growth, and look forward to an even brighter future.
